Junctional adhesion molecule 3 is a potential therapeutic target for small cell lung carcinoma
Authors:
Open Access
- 27 March 2023
- journal article
- research article
- Published by Elsevier in Experimental Cell Research
- Vol. 426 (2) , 113570
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (21K08161, 22K06962)
This publication has 20 references indexed in Scilit:
- JAM3 maintains leukemia-initiating cell self-renewal through LRP5/AKT/β-catenin/CCND1 signalingJournal of Clinical Investigation, 2018
- JAM-C Identifies Src Family Kinase-Activated Leukemia-Initiating Cells and Predicts Poor Prognosis in Acute Myeloid LeukemiaCancer Research, 2017
- Defining a Cancer Dependency MapCell, 2017
- Angiotensin-converting enzyme 2 is a potential therapeutic target for EGFR -mutant lung adenocarcinomaBiochemical and Biophysical Research Communications, 2017
- Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung CancerPLOS Genetics, 2016
- A comprehensive transcriptional portrait of human cancer cell linesNature Biotechnology, 2014
- Development of a sensitive screening method for selecting monoclonal antibodies to be internalized by cellsBiochemical and Biophysical Research Communications, 2014
- Comprehensive molecular profiling of lung adenocarcinomaNature, 2014
- A Novel Function of Junctional Adhesion Molecule-C in Mediating Melanoma Cell MetastasisCancer Research, 2011
- Cooperative expression of junctional adhesion molecule‐C and ‐B supports growth and invasion of gliomaGlia, 2009